Hypoxia-associated gene signature for uterine cervical cancer
This study developed and validated a 55-gene hypoxia-associated signature that effectively stratifies uterine cervical cancer patients by identifying those with advanced disease features and significantly worse survival outcomes, suggesting its potential utility for guiding hypoxia-targeted therapies.